Document is current
Any future updates will be listed below
-
Authors
Pfaffendorf, Christoph
Dejon-Agobé, Jean Claude
Edoa, Jean Ronald
Maïga-Ascofaré, Oumou
Ahenkan, Ebenezer
Adegnika, Ayôla Akim
Ramharter, Michael
Wicha, Sebastian G.
Mischlinger, Johannes
-
Funding
Funding for this research was provided by:
EDCTP2 (ASAAP RIA2017MC-2022)
German Center for infection Research (TTU 03.709)
Universität Hamburg
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 13 March 2026
First Online: 19 March 2026
Declarations
:
: The study conformed to the Declaration of Helsinki and Standard Operating Procedures that meet current regulatory requirements and guidelines laid down by the International Conference on Harmonisation for Good Clinical Practice in Clinical Studies. The clinical trial was approved by the relevant Independent Ethics Committees, national Institutional Review Boards, and local regulatory authorities at Centre de Recherches Médicales de Lambaréné (CERMEL) (Lambaréné, Gabon). The study protocol was registered online before start of recruitment into this clinical trial (pactr.samrc.ac.za, PACTR202008909968293).
: The authors declare no competing interests.
